Zdrowie i gospodarka · 14/05/2002

FDA Clears IFEX (Ifosfamide for Injection) for Sale After Re-Examination

The US Food and Drug Administration (FDA) has determined that IFEX, a cancer treatment medication, was not withdrawn from sale due to safety or effectiveness concerns, paving the way for the approval of generic versions of the drug.